# N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma

> **NCT00005978** · PHASE1 · COMPLETED · sponsor: **New Approaches to Neuroblastoma Therapy Consortium**

## Conditions studied

- Neuroblastoma

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** carboplatin
- **DRUG:** etoposide
- **DRUG:** melphalan
- **PROCEDURE:** autologous bone marrow transplantation
- **PROCEDURE:** peripheral blood stem cell transplantation
- **RADIATION:** iobenguane I 131
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00005978
- **Lead sponsor:** New Approaches to Neuroblastoma Therapy Consortium
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** 2004-12
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2010-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005978, "N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00005978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*